Literature DB >> 31160172

A Societies for Pediatric Urology survey of opioid prescribing practices after ambulatory pediatric urology procedures.

J J Ahn1, J S Ellison2, P A Merguerian3.   

Abstract

INTRODUCTION: Opioid dependence and abuse has been declared a national public health emergency, and overprescribing of opioids after surgery has been identified as a driving factor. To date, opioid prescribing after pediatric urology ambulatory surgery has not been well-described.
OBJECTIVE: The study's objective was to assess pediatric urologists' practices in prescribing opioids for routine ambulatory procedures. STUDY
DESIGN: A 23-question survey was created, including eight case vignettes describing routine procedures (orchiopexy, hydrocele repair, circumcision) across three age groups (8 months, 3 years, 13 years). Multiple choice questions asked about typical opioid type and duration for each case. Respondent attitudes and practice types were also evaluated. The survey was administered through the Societies for Pediatric Urology.
RESULTS: Of the 102 respondents, 48% reported prescribing postoperative opioids for all cases described (Figure 1). Fourteen percent reported prescribing no opioids for all cases. Longer prescription duration was associated with older age (p = 0.003). Acetaminophen-hydrocodone was prescribed most commonly, while a few respondents reported prescribing acetaminophen-codeine. North Central and Southeastern respondents were more likely to prescribe opioids for all cases described (p = 0.003). The majority of respondents work in academic settings and had >10 years in practice. Only 16% believe that their patients take the majority of opioids prescribed, while only 35% provide education to their patients on proper disposal. DISCUSSION: There is significant variability in reported opioid prescribing practices after ambulatory procedures amongst pediatric urologists. Only 16% of respondents believe that patients take the majority of opioids prescribed, and only 14% reported never prescribing opioids for these procedures. There is an opportunity for guidelines and standardization of care for postoperative analgesia in this patient population. Given that overprescribing can lead to abuse and misuse, further work needs to be done to establish postoperative analgesia needs and to educate providers and families on proper prescribing and disposal.
CONCLUSION: Pediatric urologists report prescribing opioids frequently after routine ambulatory procedures in infants, children, and adolescents despite believing that patients do not take the majority of the prescribed medication.
Copyright © 2019 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Opioid stewardship; Postoperative analgesia; Practice patterns

Year:  2019        PMID: 31160172     DOI: 10.1016/j.jpurol.2019.04.025

Source DB:  PubMed          Journal:  J Pediatr Urol        ISSN: 1477-5131            Impact factor:   1.830


  3 in total

1.  Laser access and utilization preferences for pediatric ureteroscopy: A survey of the Societies of Pediatric Urology.

Authors:  Ray Yong; Gregory E Tasian; Kate H Kraft; William W Roberts; Adam Maxwell; Jonathan S Ellison
Journal:  Can Urol Assoc J       Date:  2022-03       Impact factor: 1.862

2.  Provider education leads to sustained reduction in pediatric opioid prescribing after surgery.

Authors:  Bethany J Slater; Chase G Corvin; Kurt Heiss; Robert Vandewalle; Sohail R Shah; Megan Cunningham; EuniceY Huang; Aaron M Lipskar; Naomi-Liza Denning; Melvin Dassinger; Robert A Cina; David H Rothstein; Jeremy Kauffman; Raquel Gonzalez; Martha-Conley Ingram; Mehul V Raval
Journal:  J Pediatr Surg       Date:  2021-08-08       Impact factor: 2.545

3.  Opioids in Urology: How Well Are We Preventing Opioid Dependence and How Can We Do Better?

Authors:  Danyon J Anderson; David Y Cao; Jessica Zhou; Matthew McDonald; Abrahim N Razzak; Jamal Hasoon; Omar Viswanath; Alan D Kaye; Ivan Urits
Journal:  Health Psychol Res       Date:  2022-09-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.